Immunomodulatory effects of glycine on LPS-treated monocytes: Reduced TNF-α production and accelerated IL-10 expression

FASEB Journal

Volumn 13, Issue 3, 1999, Pages 563-571

  Spittler, Andreas ^a,b   Reissner, Carmen M ^a   Oehler, Rudolf ^a   Gornikiewicz, Alexander ^a   Gruenberger, Thomas ^a   Manhart, Nicole ^a   Brodowicz, Thomas ^a   Mittlboeck, Martina ^a   Boltz Nitulescu, George ^a   Roth, Erich ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antigen expression; Cytokines; Sepsis; Tumor necrosis factor; Whole blood cell

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SEPSIS;

STRYCHNOS TOXIFERA;

EID: 0033007260     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.3.563     Document Type: Article

References (38)

1. Baron, R. (1993) Pathophysiology of septic shock and implications for therapy. Clin. Pharmacol. 12, 8298-8306
2. Parillo, J. E. (1992) Pathogenetic mechanism of septic shock. New Engl. J. Med. 328, 1471-1477
3. Beutler, B. (1993) Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock. New Horiz. 1, 3-12
4. Doherty, G. M., Lange, J. R., Langstein, H. N., Alexander, H. R., Buresh, C. M., and Norton, J. A. (1992) Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149, 1666-1670
5. Beutler, B., Milsark, I. W., and Cerami, A. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871
6. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. (1989) Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095
7. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822
8. Ertel, W., Kremer, J. P., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O., and Schildberg, F. W. (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85, 1341-1347
9. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R. (1993) Interleukin-10. Annu. Rev. Immunol. 11, 165-1690
10. Taga, K., and Tosato, G. (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148, 1143-1148
11. Ding, L., and Shevach, E. M. (1992) IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148, 3133-3139
12. de Waal Malefyt, R., Haanen J., Spits, H., Roncarolo, M. G., te-Velde, A., Figdor, C. G., Johnsson, K., Kastelein, R., Yssel, H., and de Vries, J. E. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924
13. Howard, M., Muchamuel, T., Andrade, S., and Menon, S. (1993) Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208
14. Tracey, J. K., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A. ( 1987) Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nalure (London) 330, 662-664
15. Fisher, C. J., Opal, S. M., Dhainut, J. F., Stephens, S., Zimmerman, J. L., Nightingale, P., Harris, G. J., Schein, R. M., Panacek, E. A., Vinvent, J. L., Foulke G. E., Warren, E. L., Garrard C., Park G., Bodmer M. W., Cohen J., Linden van der C., Cross A. S., Sardoff, J. C., and the CB0006 Sepsis Syndrome Study Group. (1993) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med. 21, 318-327
16. Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., Benjamin, E., and memhers of the Soluble TNF Receptor Study Group. (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. New Engl. J. Med. 334, 1697-1702
17. Griffiths, R. D., Jones, C., and Palmer, T. E. (1997) Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13, 295-302
18. Houdijk, A. P. J., Rijnsburger, E. R., Jansen, J., Wesdorp, R. I. C., Weis, J. K., McCamish, M. A., Teerlink, T., Meuwissen, S. G. M., Haarman, H. J. Th. M., Thijs, L. G., and van Leeuwen, P. A. M. (1998) Glutamine enriched enteral nutrition reduces infectious morbidity in multitrauma patients: a randomized double blind trial. JPEN 22, S2
19. Spittler, A., Winkler, S., Goetzinger, P., Oehler, R., Willheim, M., Tempfer, C., Weigel, G., Fuegger, R., Boltz-Nitulescu, G., and Roth, E. (1995) Influence of glutamine on the phenotype and function of human monocytes. Blood 86, 1564-1569
20. Ikejima, K., Iimuro, Y., Forman, D. T., and Thurman, R. G. (1996) A diet containing gylcine improves survival in endotoxin shock in the rat. Am. J. Physiol. 271, G97-G103
21. Ikejima, K., Qu, W., Stachlewitz, R. F., and Thurman, R. G. (1997) Kupffer cells contain a glycine-gated chloride channel. Am. J. Physiol. 272, G1581-G1586
22. Marsh, D. G., Vreugdenhil, P. K., Mack, V. E., Belzer, F. O., and Southard, J. H. (1993) Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress. Hepatology 17, 91-98
23. Zhong, Z., Jones, S., and Thurman, R. G. (1996) Glycine minimizes reperfusion injtny in a low-flow, reflow liver perfusion model in the rat. Am. J. Physiol. 270, G332-G338
24. Weinberg, J. M., Davis, J. A., Roeser, N. F., and Venkatachalam, M. A. (1991) Role of increased cytosolic free calcium in the pathogensis of rabbit proximal tubule cell injury and protection by glycine or acidosis. J. Clin. Invest. 87, 581-590
25. Weinberg, J. M., Davis, J., Abarzua, M., and Rajyn, T. (1987) Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J. Clin. Invest. 80, 1446-1454
26. Thurman, R. G., Zhong, Z., von Frankenberg, M., Stachlewitz, R. F., and Bunzendahl, H. (1997) Prevention of cyclosporine-induced nephrotoxicity with dietary glycine. Transplant 63, 1661-1667
27. Spittler, A., Schiller, C., Willheim, M., Tempfer, C., Winkler, S., and Boltz-Nitulescu, G. (1995) IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultred human blood monocytes: effects of IE-10 and other cytokines on cell phenotype and phagocytosis. Immunology 85, 311-317
28. Jung, T., Schauer, U., Heusser, C., Neumann, C., and Rieger, C. (1993) Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159, 197-207.
29. Fisher, C. J., Dhainut, J. F., Opal, S. M., Pribble, J. P., Balk, R. A., Slotman, G. J., Iberti, T. J., Rackow, F., C., Shapiro, M. J., Greenman, R. L., Reines H. D., Shelly M. P., Thompson B. W., LaBrecque J. F., Catalano M. A., Knaus W. A., and Sadoff J. C., for the Phase III rhIL-1ra Sepsis Syndrome Study Group. (1994) Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double blind, placebo-controlled trial. Phase rhIL-1ra sepsis syndrome study group. J. Am. Med. Assoc. 271, 1836-1843
30. Bone, R. C., Balkm R. A., Fein, A. M., Perl, T. M., Wenzel, R. P., Reines, H. D., Quenzer, R. W., Iberti, T. J., MacIntyre, N., and Schein, R. M. (1995) A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, clinical trial. Crit. Care Med. 23, 994-1006
31. Greenman, R. I., Schein, R. M., Martin, M. A., Wenzel, R. P., MacIntyre, N. R., Emmanuel, G., Chmel, H., Kohler, R. B., McCarthy, M., Plouffe, J., Russel, J. A., and the XOMA Sepsis Study Group. (1991) A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. J. Am. Med. Assoc. 266, 1097-1102
32. Abraham, E., Wumderink, R., Silverman, H., Perl, T. M., Nasraway, S., Levy, H., Bone, R., Wenzel, R. P., Balk, R., Allred, Pennington, J. E., and Wherry, J. C., for the TNK-α MAh Sepsis Study Group. (1995) Efficiacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome. J. Am. Med. Assoc. 273, 934-941
33. Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., and Thompson, R. C. (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (London) 348, 550-552
34. Dhainaut, J. F., Tenaillon, A., Le Tulzo, Y., Schlemmer, B., Solet, J. P., Wolff, M., Holzapfel, L., Zeni, F., Dreyfuss, D., Mira, J. P., de Vathaire, F., Guinot, P., and the BN 52021 Sepsis Study Group. (1994) Platelet-activating factor receptor antagonist BN 52021 in ihe treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Crit. Care Med. 22, 1720-1728
35. De Waal Malefyt, R., Abrams, J., Bennet, B., Figdor, C. G., and de Vries, J. F. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220
36. Wang, R., Fiding, Q., Zhang, L., Radvany, L., Sharina, A., Noben-Trauth, N., Mills, G. M., and Shi, Y. (1997) CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression. J. Immunol. 158, 2856-2861
37. Standiford, T. J., Strieter, R. M., Lukacs, N. W., and Kunkel, S. L. (1995) Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155, 2222-2229
38. 3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis. Immunology 90, 286-293